Skip to main content

Advertisement

Table 1 Distribution and characterisation of the groups

From: Allergic sensitisation in tuberculosis patients at the time of diagnosis and following chemotherapy

  Controls Tuberculosis patients
   A: Before treatment B: Subgroup;
follow-up analyses
Number 216 108 71
Gender (%) (females, males) 33.5/66.5 33.3/66.7 27.8/72.2
Age, Mean ± SD 41.1 ± 15.5 40.1 ± 14.8 40.4 ± 15.0
Smoking, no/yes (%) 53.2/46.8 59.5/40.5 62.5/37.5
BCG scar, absent/present/unknown (%), 75.2/18.3/6.4 91/8.1/0.9 90.3/9.7/0
Reported allergy, n (%) 14 (6.4) 21 (18.9) 13 (18.1)
Weeks of TB symptoms
Mean ± SD
  10.5 ± 5.7 10.4 ± 5.9
  1. BCG = Bacillus Calmette-Gu, rin, A: These patients were included in the analyses between tuberculosis patients and healthy controls. B: The subgroup consisted of 71 patients which were followed-up after treatment. These patients were included in paired-analyses concerning before and after tuberculosis treatment.